Immix Biopharma, Inc. (IMMX)
14.31
+0.24
(+1.71%)
USD |
NASDAQ |
Aug 27, 16:00
14.31
0.00 (0.00%)
After-Hours: 18:10
Immix Biopharma Price to Book Value : 4.472 for Aug. 27, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 4.397 |
| August 25, 2026 | 4.522 |
| August 24, 2026 | 4.253 |
| August 21, 2026 | 4.269 |
| August 20, 2026 | 4.112 |
| August 19, 2026 | 4.122 |
| August 18, 2026 | 3.691 |
| August 17, 2026 | 3.544 |
| August 14, 2026 | 3.428 |
| August 13, 2026 | 3.412 |
| August 12, 2026 | 3.553 |
| August 11, 2026 | 3.591 |
| August 10, 2026 | 3.166 |
| August 07, 2026 | 3.038 |
| August 06, 2026 | 3.144 |
| August 05, 2026 | 2.981 |
| August 04, 2026 | 2.916 |
| August 03, 2026 | 2.631 |
| July 31, 2026 | 2.60 |
| July 30, 2026 | 2.672 |
| July 29, 2026 | 2.553 |
| July 28, 2026 | 2.638 |
| July 27, 2026 | 2.716 |
| July 24, 2026 | 2.662 |
| July 23, 2026 | 2.75 |
| Date | Value |
|---|---|
| July 22, 2026 | 2.941 |
| July 21, 2026 | 2.991 |
| July 20, 2026 | 2.75 |
| July 17, 2026 | 3.203 |
| July 16, 2026 | 3.144 |
| July 15, 2026 | 3.291 |
| July 14, 2026 | 3.338 |
| July 13, 2026 | 3.288 |
| July 10, 2026 | 3.472 |
| July 09, 2026 | 3.466 |
| July 08, 2026 | 3.438 |
| July 07, 2026 | 3.756 |
| July 06, 2026 | 3.266 |
| July 02, 2026 | 3.231 |
| July 01, 2026 | 3.072 |
| June 30, 2026 | 3.222 |
| June 29, 2026 | 6.592 |
| June 26, 2026 | 6.271 |
| June 25, 2026 | 6.108 |
| June 24, 2026 | 6.309 |
| June 23, 2026 | 6.227 |
| June 22, 2026 | 5.907 |
| June 18, 2026 | 5.479 |
| June 17, 2026 | 5.737 |
| June 16, 2026 | 5.492 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Savara, Inc. | 7.856 |
| SELLAS Life Sciences Group, Inc. | 22.32 |
| Atossa Therapeutics, Inc. | 0.9783 |
| Marker Therapeutics, Inc. | 2.022 |
| Krystal Biotech, Inc. | 7.782 |
Price to Book Value Related Metrics
| PEG Ratio | -1.451 |
| Price | 14.31 |
| Earnings Yield | -6.15% |
| Market Cap | 1.024B |
| PEGY Ratio | -1.451 |